Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
Guest Alerts | Access Rights | My Account | Sign In
|
|
Sci. STKE, 10 October 2006 REVIEWSMolecular Signaling Mechanisms Underlying Epileptogenesis
James O. McNamara1,2,3*,
1Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA. Gloss: The epilepsies, disorders of recurrent seizures, affect about 1% of the population worldwide. Available therapy is symptomatic in that drugs inhibit seizures but are not disease-modifying; that is, no effective pharmacological prevention or cure has been identified. The term "epileptogenesis" refers to the process by which a normal brain becomes epileptic. Understanding the cellular mechanisms of epileptogenesis in molecular terms may help identify molecular targets for which small-molecule therapeutics can be developed to prevent epileptogenesis in individuals at high risk. A number of acquired and genetic causes of this disorder have been identified, and various in vivo and in vitro models of epileptogenesis have been established. The objective of this STKE Review, with 5 figures, 2 tables, and 199 references, is to review current insights into the molecular signaling mechanisms underlying epileptogenesis, focusing on limbic epileptogenesis in particular. *Corresponding author. Telephone, 919-684-0320; fax, 919-684-8219; e-mail, jmc{at}neuro.duke.edu
Citation: J. O. McNamara, Y. Z. Huang, A. S. Leonard, Molecular Signaling Mechanisms Underlying Epileptogenesis. Sci. STKE 2006, re12 (2006). The editors suggest the following Related Resources on Science sites:In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)